Fondsfinans Norge vs UBS Lux Equity Fund Biotech USD

Security

Fondsfinans Norge B
Fee

0.99%
ISIN

NO0013168708
Holdings

24

Security

UBS Lux Equity Fund Biotech USD P-acc
Fee

2.25%
ISIN

LU0069152568
Holdings

10

Fund Holdings

We have information about 28 holdings in Fondsfinans Norge, where the largest holding is Orkla (8.04), followed by Mowi (6.92) and Equinor (6.16). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Fondsfinans Norge and UBS Lux Equity Fund Biotech USD.

Fondsfinans Norge	UBS Lux Equity Fund Biotech USD
1. Orkla Foods AS 8.04 %	1. Regeneron Pharmaceuticals Inc 10.04 %
2. Mowi 6.92 %	2. Vertex Pharmaceuticals Inc 9.35 %
3. Equinor ASA 6.16 %	3. Moderna Inc 9.21 %
4. Schibsted B 6.05 %	4. Alnylam Pharmaceuticals Inc 6.96 %
5. Austevoll Seafood ASA 5.86 %	5. AbbVie Inc 5.53 %
6. Gjensidige Forsikring 4.51 %	6. Gilead Sciences Inc 4.66 %
7. SpareBank 1 Sør-Norge ASA 4.28 %	7. Amgen Inc 4.3 %
8. DNB Bank 3.81 %	8. BioNTech SE 4.13 %
9. Aker BP 3.79 %	9. Karuna Therapeutics Inc 3.75 %
10. SATS ASA 3.59 %	10. Royalty Pharma Plc 3.37 %
11. Frontline ASA 3.39 %	-
12. Tomra Systems ASA 3.15 %	-
13. Wilh. Wilhelmsen Holding A 3.1 %	-
14. Kitron ASA 3 %	-
15. Norsk Hydro ASA 2.74 %	-
16. Röko AB 2.41 %	-
17. SalMar ASA 2.32 %	-
18. Crayon Group Holding ASA 2.11 %	-
19. Pareto Bank ASA 2.11 %	-
20. Yara International ASA 2.06 %	-
21. Vår Energi ASA 2.06 %	-
22. Nordic Semiconductor ASA 1.99 %	-
23. Public Property Invest ASA 1.99 %	-
24. Europris ASA 1.97 %	-

The list of fund holdings was last updated on June 5, 2025.